Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ensuring vaccine safety in immunization programmes--a WHO perspective.

L Jodar1, P Duclos, J B Milstien

  • 1Vaccines & Biologicals, Health Technology and Pharmaceuticals, World Health Organization, 20 Avenue Appia, 1211 27, Geneva, Switzerland. jodarl@who.int

Vaccine
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimated number of symptomatic Lyme borreliosis cases in Germany in 2021 after adjusting for under-ascertainment.

Public health·2023
Same author

Two apparently unrelated groups of symbiotic annelids, Nautiliniellidae and Calamyzidae (Phyllodocida, Annelida), are a clade of derived chrysopetalid polychaetes.

Cladistics : the international journal of the Willi Hennig Society·2021
Same author

Vaccine vigilance in Canada: Is it as robust as it could be?

Canada communicable disease report = Releve des maladies transmissibles au Canada·2018
Same author

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.

The British journal of surgery·2017
Same author

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.

Vaccine·2016
Same author

Furosemide continuous rate infusion diluted with 5% dextrose in water or hypertonic saline in normal adult dogs: a pilot study.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2016

Adverse events following immunization (AEFIs) are increasingly reported globally. The WHO is enhancing vaccine safety through new technologies and training to ensure safe immunization for all children.

Area of Science:

  • Public Health
  • Immunology
  • Vaccinology

Background:

  • Adverse events following immunization (AEFIs) have been documented since the earliest vaccines.
  • Increased public and media attention has heightened concerns about vaccine safety, potentially impacting global immunization programs.
  • Perceptions of vaccine safety have shifted despite the unchanged efficacy of established vaccines.

Purpose of the Study:

  • To address the growing concerns and challenges related to adverse events following immunization.
  • To outline the World Health Organization's (WHO) ongoing and future strategies for ensuring vaccine safety.
  • To highlight the importance of adapting to new technologies and public perceptions in maintaining trust in immunization.

Main Methods:

  • Review of historical data on AEFIs.

Related Experiment Videos

  • Analysis of current trends in vaccine safety reporting and public perception.
  • Description of WHO's initiatives, including the Safe Injection Global Network (SIGN).
  • Exploration of new immunization technologies and training programs.

    • Main Results:

    • AEFIs are a recognized aspect of immunization programs, with increasing reports expected as coverage expands.
    • Public and media interest significantly influences the perception of vaccine safety.
    • WHO has a long-standing commitment to vaccine safety, with evolving strategies to address new challenges.

    Conclusions:

    • WHO is actively implementing strategies to guarantee vaccine safety, including safer injection technologies and improved detection/management of AEFIs.
    • Continuous training and adaptation to new technologies are crucial for minimizing human error and ensuring vaccine safety.
    • Proactive measures are in place to detect and respond to unforeseen events, ensuring safe immunization for children worldwide.